ARCHIVES

Von Eschenbach Says He Will Step Down as NCI Director; No Acting Director Has Been Named.

This article is from The Cancer Letter archive.

Vol. 32 No. 11 | March 24, 2006

Download PDF Visit The Full Archive

Related Articles

Oncology Management: US Oncology To Conduct Up To 5 Studies Of PG-TXL In Colorectal, Lung Cancers

June 1, 2001

Doroshow: NCI Leaves It Up to Groups To Make Their Own Merger Deals

February 11, 2011

Waksals Keep ImClone Jobs, BMS Pumps $200M Into C225

March 8, 2002

Trials Could Start Earlier If Model Contract Language Adopted, NCI and CEO Roundtable Say.

December 12, 2008

Clinical Research Needs Payment Mechanism, Kerrey

February 4, 1994

NCI Implements Changes To Speed Up New Drug Development; compounds In Pipeline Listed

July 9, 1976